LIMS & Lab Automation
Tri-coded sample tubes deliver secure, traceable storage
Keeping samples safe, identifiable, and fully traceable is critical in biobanks, compound libraries, and high- density cryogenic storage. The FluidX™ Tri-Coded Sample Tubes from Azenta Life Sciences are engineered to meet these demands, combining robust security with advanced tracking capabilities for modern laboratories.
Unlike internal-thread designs, the externally threaded tubes cannot be overtightened and allow a higher working volume, while ensuring a tight, reliable seal to safeguard sample integrity. Proprietary tri-coding technology provides a permanent link between sample and data: each tube features a laser-etched 2D code on the base, a 1D linear barcode, and a human-readable number on the side. High-contrast codes remain scannable even under frost or condensation, supporting easy identification without removing tubes from racks.
Designed for high-throughput and automated workflows, the tubes are compatible with both semi-automated and fully automated systems, enabling efficient sample
tracking, data sharing, and cross-lab collaboration. Manufactured from USP Class VI virgin polypropylene in a Class 8 cleanroom, every batch is rigorously tested to be free from extractables, leachables, endotoxin, DNA/RNA, and heavy metals, protecting your valuable samples from contamination.
Broad compatibility ensures seamless integration with Azenta Life Sciences’ automated capping, code reading, and sample management systems - as well as with industry-standard platforms.
Request a free trial pack of FluidX Tri-Coded Sample Tubes:
ilmt.co/PL/8eK6 More information online:
ilmt.co/PL/ZO73
65993pr@reply-direct.com
Thermo Fisher Scientific has unveiled Chromeleon 7.4, a new enterprise- and compliance-ready software platform for chromatography and mass spectrometry (MS) workflows. Supporting single quad, triple quad, and high- resolution accurate mass (HRAM) analyses, the software is designed to streamline data management in both regulated and non-regulated laboratory environments.
Streamlined automation advances T-cell cancer research
3T Biosciences, a biotech company pioneering immune-based therapies for solid tumours, is accelerating its drug discovery workflows with the help of automation tools from Integra Biosciences.
The South San Francisco-based company specialises in identifying novel peptide-HLA targets for T-cell engaging bispecific antibodies using its proprietary 3T-TRACE™ platform. By combining diverse antigen libraries with machine learning, the platform enables high- resolution mapping of tumour-specific immune responses - critical to uncovering the most prevalent immunogenic targets in solid cancers.
To support growing demands for precision and throughput, the team has integrated Integra’s ASSIST PLUS pipetting robot alongside the D-ONE single channel module into their workflows. These tools are being used for tasks such as protein normalisation and aliquoting - processes that benefit from consistent and accurate liquid handling.
“Our goal is to build scalable, reproducible workflows that can adapt to the complexity
of therapeutic discovery,” said Jake Kleiner, Associate Scientist at 3T Biosciences. “The ASSIST PLUS, combined with Integra’s intuitive VIALAB software, allows us to rapidly deploy automated protocols without needing extensive programming knowledge. It’s already had a noticeable impact on efficiency and reproducibility.”
In addition to automation, the lab continues to rely on Integra’s manual pipettes for flexible, hands-on workflows. Looking ahead, 3T Biosciences aims to expand automation into more of its screening and assay development activities.
Kleiner added: “We’re now exploring how automation can increase our high-throughput capacity and standardise more of our assays. These improvements will help us push therapeutic candidates forward more rapidly.”
More information online:
ilmt.co/PL/j9kq 65121pr@reply-direct.com
Chromeleon 7.4 helps scientists and lab managers focus on results rather than administrative tasks. Mass spectrometry generates large volumes of complex data, which can be difficult to process and analyse efficiently. By consolidating workflows into a single connected platform, the software automates targeted screening and quantitation, reducing manual intervention and minimising the risk of errors.
Unlike traditional workstation-based MS software, Chromeleon 7.4 manages all aspects of networked operation. It provides concurrency management, network failure protection, and consistent handling of analyses across instruments. Researchers can access data remotely, share results between labs, and maintain uniform software usage, eliminating the need to learn multiple disconnected systems.
The software is aimed at analytical scientists, super-users, and lab managers in biopharmaceutical, environmental, and food testing laboratories. It is particularly suited for teams that require compliance with regulatory standards or want to leverage enhanced connectivity to increase efficiency and consistency across their operations.
Chromeleon 7.4 also offers improved data visualisation, allowing users to examine single-scan fragments and simulated isotopic patterns for more accurate analyte identification and quantitation. Centralised data storage ensures integrity and traceability, while built-in audit trails, electronic signatures, and secure user management support GxP and 21 CFR Part 11 compliance.
The Spotlight could be on you!
Check out our Media Information Pack for further details and send your Press Releases to
pr@intlabmate.com
By combining enterprise readiness, compliance support, and advanced data handling, Chromeleon 7.4 provides laboratories with a powerful platform to accelerate analysis, enhance reliability, and improve overall scientific outcomes.
More information online:
ilmt.co/PL/1nKV 65943pr@reply-direct.com
Next-generation MS and chromatography platform simplifi es lab workfl ows and compliance
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
